A study published in The BMJ found that eating three servings of French fries per week increases type 2 diabetes risk by 20%, while other potato preparations like baked, boiled, or mashed potatoes do not. The study, led by Harvard University, highlights that dietary context and preparation methods significantly influence health outcomes. Researchers note limitations, including confounding factors like overall diet and lifestyle, and emphasize the need to consider how food is paired with other items for a balanced approach to diabetes prevention.

CVR Partners' IBD SmartSelect Composite Rating increased to 96, indicating strong performance relative to other stocks. The company reported a 48% Q2 earnings increase with 27% top-line growth, and has posted accelerating growth for five consecutive quarters. It ranks No. 1 in the Chemicals-Agriculture industry group, alongside CF Industries Holdings and Intrepid Potash.

The article discusses recent insider selling by Robert Jornayvaz, a major shareholder of Intrepid Potash, who sold $1.8 million worth of stock at $34.30 per share, representing 93% of his holdings. This follows a prior sale of $6.2 million at $26.24 per share. Insiders own 2.9% of the company's shares (worth $13 million), but the frequent sales raise concerns about potential undervaluation. The article highlights the risks associated with insider transactions and advises caution before investing.

The NPK fertilizers market was valued at USD 95 billion in 2024 and is projected to reach USD 135 billion by 2033, growing at a 4.3% CAGR. The market is driven by rising food demand, technological advancements, and sustainable farming practices, with Asia Pacific leading due to extensive agricultural activity. Key players include Nutrien Ltd., Yara International ASA, and others. The report analyzes market drivers, competitive landscape, and regional growth opportunities.

The article analyzes Intrepid Potash's declining Return on Capital Employed (ROCE) of 1.0%, which underperforms the Chemicals industry average of 10%. Over five years, ROCE has dropped from 2.2% to 1.0%, with capital employed remaining stable, suggesting a mature business with limited growth. Despite a 303% stock increase over five years, the company's fundamentals are deemed weak, and investors are advised to be cautious.